AI Powered Trial Enablement
AI-enabled pathology and clinical data intelligence to support more efficient patient identification, eligibility assessment, and trial enrollment.
NECCR is integrating Santovia Path AI’s SAINT tool to bring advanced artificial intelligence and pathology intelligence into the clinical trial environment. The platform is designed to help identify and evaluate potential study participants by analyzing pathology (historical and present lab values) and clinical data, supporting more efficient patient screening, eligibility assessment, and trial enrollment.
Driving the future of clinical research
By incorporating AI-enabled pathology insights into the research workflow, Santovia Path AI can help research teams better understand patient populations, streamline data review, and support more informed clinical trial decisions. This technology strengthens NECCR’s ability to offer sponsors a more efficient, data-driven approach to clinical research—from patient identification and study startup through trial execution.